Cases & Deals

Hookipa Pharma completes $84 million IPO

Clients Hookipa Pharma Inc.

Jones Day served as IP counsel in connection with the $84 million initial public offering of Hookipa Pharma Inc. (NASDAQ: HOOK). Hookipa is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on their proprietary arenavirus platform that is designed to reprogram the body's immune system.